Business Wire

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area

SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO) member of Blood Centers of America (BCA), today announced that it has been selected ...
Seeking Alpha

TC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial Requirements

EDINBURGH, Scotland, Oct. 25, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC (TCBP) ("TC BioPharm" or the "Company") a clinical stage biotechnology company developing platform allogeneic gamma-delta ...
Business Wire

Excellos Announces Strategic Partnership and Investment from Vitalant

SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with Vitalant, one of the nation’s largest ...
KTLA

Excellos, Lonza, and Akadeum Life Sciences Unite to Advance Cell Therapy Manufacturing Through Enhanced Starting Material Quality

ANN ARBOR, Mich., Aug. 6, 2025 /PRNewswire/ -- Excellos, Lonza, and Akadeum Life Sciences today announce a new project aimed at redefining standards for cell therapy manufacturing by elevating the ...
Nasdaq

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area

Excellos is the first decentralized manufacturing unit (DMU) within the nationwide network of Blood Centers of America to be selected for Good Manufacturing Compliant (GMP) manufacturing for Galapagos ...